Key Takeaways
- • Molly Fitzpatrick, profiled in McGuireWoods' Women in Private Equity series, shifted from a pre-med track at the University of Notre Dame to finance after concluding she would not tolerate medical school's exposure to blood.
- • Fitzpatrick earned an MBA at Harvard and began her career in investment banking, building valuation models and analyzing mergers and acquisitions.
- • Her interest in healthcare investing was shaped by a company whose services let premature babies leave neonatal intensive care units earlier than prevailing best practice, benefiting infants, parents, and payers such as insurers and Medicaid.
- • Fitzpatrick joined Halifax Group as an associate in 2011, the start of a relationship she describes as defining her career.
Summary
Molly Fitzpatrick's path into private equity began at the University of Notre Dame, where she initially pursued a pre-med degree. According to her account in the McGuireWoods interview, she abandoned that track because of a physical limitation: "I get very queasy, so I didn't think medical school was going to go well." Through other coursework, she found an alternative that did not require tolerance for blood. She came to see how business leaders create jobs, deliver useful products and services, and reinvest in their communities, and she shifted her studies to finance. She subsequently earned an MBA at Harvard.
Her first professional role was in investment banking, where she built valuation models, analyzed mergers and acquisitions, and learned the mechanics of deal-making. Fitzpatrick described the work as demanding but rewarding, citing the variety of transactions, as no two were alike, and the analytical challenge of determining what drives a company's performance.
Fitzpatrick said her investment focus was also shaped by the human impact of businesses. She recalled hearing a management team explain how its services enabled premature babies to leave neonatal intensive care units sooner than the prevailing best practices of the time. The outcome benefited babies and parents, as well as the insurers and Medicaid programs paying for NICU care. She framed this as the "win-win situation that I look for in healthcare businesses," adding that helping companies grow to serve more patients while saving the healthcare system money is what motivates her.
In 2011, Fitzpatrick joined Halifax Group as an associate, a move the interview presents as the start of a relationship that would define her career. The profile is part of McGuireWoods' ongoing series recognizing women leaders in private equity and finance.
Her first professional role was in investment banking, where she built valuation models, analyzed mergers and acquisitions, and learned the mechanics of deal-making. Fitzpatrick described the work as demanding but rewarding, citing the variety of transactions, as no two were alike, and the analytical challenge of determining what drives a company's performance.
Fitzpatrick said her investment focus was also shaped by the human impact of businesses. She recalled hearing a management team explain how its services enabled premature babies to leave neonatal intensive care units sooner than the prevailing best practices of the time. The outcome benefited babies and parents, as well as the insurers and Medicaid programs paying for NICU care. She framed this as the "win-win situation that I look for in healthcare businesses," adding that helping companies grow to serve more patients while saving the healthcare system money is what motivates her.
In 2011, Fitzpatrick joined Halifax Group as an associate, a move the interview presents as the start of a relationship that would define her career. The profile is part of McGuireWoods' ongoing series recognizing women leaders in private equity and finance.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.